Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

immunity · Mechanism Report

Does low vitamin D increase risk of autoimmune thyroid disease by impairing immune tolerance?

Low vitamin D status is strongly associated with higher prevalence and severity of autoimmune thyroid disease, and vitamin D signaling promotes immune tolerance by suppressing pro-inflammatory Th1/Th17 responses and supporting regulatory pathways.

PlausibleJune 19, 202619 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Low vitamin D status is associated with autoimmune thyroid disease, and vitamin D supports immune tolerance by shifting immune signaling away from pro-inflammatory, autoreactive responses.

laying out figure…
2 of 5 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

Extensive observational and genetic data link lower serum 25(OH)D to increased odds of autoimmune thyroid disease and higher thyroid antibody levels, with a dose-response relationship as levels fall. Mechanistically, vitamin D acting through the vitamin D receptor represses NF-κB–driven pro-inflammatory cytokines, inhibits Th1/Th17 effector differentiation, and promotes tolerogenic dendritic cells and FoxP3+ regulatory T cells that support peripheral self-tolerance.

Verified conclusion

Clinical evidence

The association between low vitamin D status and autoimmune thyroid disease (AITD)—specifically Hashimoto's thyroiditis and Graves' disease—is supported by extensive observational data and meta-analyses.

  • Prevalence and Risk: Research consistently shows that patients with AITD have significantly lower serum 25-hydroxyvitamin D [25(OH)D] levels than healthy controls. In middle-aged women, vitamin D deficiency is associated with nearly double the odds of testing positive for thyroid peroxidase antibodies (TPOAb) (OR 1.96, 95% CI: 1.18–3.27).
  • Causality and Genetics: Mendelian randomization studies, which use genetic variants as proxies for environmental exposures, have demonstrated that genetically lower vitamin D levels correlate with higher TPOAb concentrations. Furthermore, polymorphisms in the vitamin D receptor (VDR) gene are linked to increased susceptibility to AITD, suggesting a functional role for vitamin D signaling in the disease's pathogenesis.
  • Clinical Metrics: Clinical studies indicate a dose-response relationship; as vitamin D levels drop below 20-30 ng/mL, the risk of thyroid autoimmunity and the severity of antibody titers increase significantly.

Mechanistic explanations

Vitamin D acts as a potent immunomodulator by binding to the VDR, which is expressed in most immune cells, to shift the immune system from a pro-inflammatory state to one of self-tolerance.

  • Effector Cell Suppression: Active vitamin D (1,25(OH)2D3) directly inhibits the differentiation of Th1 and Th17 cells, the primary drivers of autoimmune tissue damage. It accomplishes this by repressing the NF-κB pathway and reducing the production of pro-inflammatory cytokines like IL-6, IL-17, IL-23, and IFN-γ.
  • Promotion of Tolerance: Vitamin D promotes the development of "tolerogenic" dendritic cells. These specialized cells have reduced expression of co-stimulatory molecules (CD80, CD86) and produce higher levels of the anti-inflammatory cytokine IL-10.
  • Treg Induction: The environment created by tolerogenic dendritic cells favors the induction and stability of FoxP3+ regulatory T cells (Tregs). These cells are essential for maintaining peripheral tolerance and suppressing autoreactive T cells that would otherwise attack thyroid tissue.

Bottom line

Low vitamin D status is strongly linked to the presence and severity of autoimmune thyroid disease. Mechanistically, vitamin D supports immune tolerance by suppressing pro-inflammatory Th17/Th1 responses and promoting the regulatory T cell pathways necessary to prevent the immune system from attacking self-tissues.

References

  1. Low levels of serum vitamin D3 are associated with autoimmune thyroid disease in pre-menopausal women. — pmc.ncbi.nlm.nih.gov ↗
  2. Relationship Between Serum 25-Hydroxyvitamin D Deficiency and Thyroid Disease in Postmenopausal Women with Type 2 Diabetes Mellitus — pmc.ncbi.nlm.nih.gov ↗
  3. 25 Hydroxyvitamin D Deficiency and Its Relationship to Autoimmune Thyroid Disease in the Elderly — pmc.ncbi.nlm.nih.gov ↗
  4. Bidirectional Mendelian Randomization Analysis for Vitamin D and Thyroid Peroxidase Antibody — pmc.ncbi.nlm.nih.gov ↗
  5. Bidirectional Mendelian Randomization Analysis for Vitamin D and Thyroid Peroxidase Antibody — downloads.hindawi.com ↗
  6. Serum 25-hydoxyvitamin D concentrations in relation to Hashimoto’s thyroiditis: a systematic review, meta-analysis and meta-regression of observational studies — link.springer.com ↗
  7. Vitamin D and Selenium: Review of Clinical Trials of Synergistic Effects on Thyroid Antibody Levels and Disease Progression in Hashimoto’s Thyroiditis — apcz.umk.pl ↗
  8. Vitamin D and autoimmune thyroid diseases — nature.com ↗
  9. Serum Vitamin D Status in Newly Diagnosed Hypothyroid Patients — banglajol.info ↗
  10. A review of the critical role of vitamin D axis on the immune system. — linkinghub.elsevier.com ↗
  11. The Vitamin D Receptor and T Cell Function — pmc.ncbi.nlm.nih.gov ↗
  12. Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists. — linkinghub.elsevier.com ↗
  13. Immunomodulatory Properties of Vitamin D in the Intestinal and Respiratory Systems — pmc.ncbi.nlm.nih.gov ↗
  14. Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor — pmc.ncbi.nlm.nih.gov ↗
  15. 1,25-Dihydroxyvitamin D3 and IL-2 Combine to Inhibit T Cell Production of Inflammatory Cytokines and Promote Development of Regulatory T Cells Expressing CTLA-4 and FoxP31 — pmc.ncbi.nlm.nih.gov ↗
  16. Tumor Suppressor Adenomatous Polyposis Coli Sustains Dendritic Cell Tolerance through IL-10 in a β-Catenin-Dependent Manner. — academic.oup.com ↗
  17. Vitamin D–VDR Novel Anti-Inflammatory Molecules—New Insights into Their Effects on Liver Diseases — mdpi.com ↗
  18. Role of vitamin D/VDR nuclear translocation in down-regulation of NF-κB/NLRP3/caspase-1 axis in lupus nephritis. — linkinghub.elsevier.com ↗
  19. Vitamin D/VDR attenuate cisplatin-induced AKI by down-regulating NLRP3/Caspase-1/GSDMD pyroptosis pathway. — linkinghub.elsevier.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible10 sourcesDoes low-normal vitamin D weaken immune resilience?→Plausible11 sourcesCan low zinc and low vitamin D constrain immune pathways while an optimal hs-CRP does not support active systemic inflammation?→